Hui Shao, M.D., Ph.D., an assistant professor of pharmaceutical outcomes and policy in the University of Florida College of Pharmacy, was elected Director of Academics for the China Health Policy and Management Society, or CHPAMS. The society is home to more than 2,000 researchers and scholars around the world who are invested in health policy and public health in China.
As Director of Academics, Shao will organize CHPAMS’ annual conference and develop two webinar series focused on introducing advanced methods in health economics and health services research and issues-driven research topics.
According to Shao, the China Health Policy and Management Society is one of the largest and most influential economic and health science research societies in the world focused primarily on issues of the Chinese health system. He joined the organization in 2015 and this is his first leadership position.
“I’m very interested in Chinese public health research because the Chinese and U.S. health systems are very distinct from each other,” Shao said. “One is extremely centralized and heavily regulated by the government and the other is very scattered and market-driven. There is a lot to learn from each system, and as a researcher being able to walk in both worlds, there are a lot of innovative ideas that can be cultivated looking through the lens of both health systems.”
Shao was born and raised in Jinan, China, and earned a Doctor of Medicine and a Master of Health Administration degree from Shandong University. In August 2012, he moved to the U.S. to pursue a Ph.D. in global health policy and management at Tulane University. After completing that degree, he was hired in 2019 as an assistant professor in the UF College of Pharmacy.